Light therapy device for brain bleeding in premature newborns
Tests a light therapy device in newborns with severe brain bleeding.
Key facts
- Who runs it
- Rutgers, The State University of New Jersey
- Where
- Newark, United StatesSee the 2 sites
- Trial code
- Registry title
- Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
- Status
- Recruiting
- People taking part
- 24 people, planned
- Started
- 25 Feb 2025
- Expected to end
- 31 Jul 2028
- Type of study
- Interventional
- Treatments tested
- Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity
- Record updated
- 22 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for newborn babies with bleeding in the fluid spaces of the brain (intraventricular hemorrhage, IVH) grade 3 or 4. They are less than 1 month old.
- Age
- From 0 days to 1 month old
- Sex
- All
- Disease stage
- Intraventricular hemorrhage (IVH) grade 3 or 4
Main reasons for not taking part
- Babies without IVH grade 3 or 4
- Babies older than 1 month
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- neonates with intraventricular hemorrhage grade 3 or 4 less than 1 month old
Who cannot take part
- neonates without IVH grade 3/4 or older than 1 month
Where in United States
- Newark Beth Israel Medical CenterNewark, United StatesContact: Garrett GianneschiTaking people
- Rutgers New Jersey Medical School/University HospitalNewark, United StatesContact: Garrett Gianneschi, DOTaking people
About the trial
What the trial wants to find out
The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers\' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.
The group in the trial
- Non-blinded, open label experimental armTreatment being tested
The experimental arm will be administered treated with the study device. It will be 10 mW/cm\^2 of 650nm laser through use of a novel laser device given for 5 minutes twice daily for 12 days.
Treatment: Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
- Plain-language title
- Light therapy device for brain bleeding in premature newbornsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 22 July 2025